Nautilus Biotechnology
James Wang PhD is an experienced professional in reagent development and process engineering, currently serving as Manager of Reagent Process Development at GRAIL since June 2021. In this role, James manages a team focused on Multi-Cancer Early Detection (MCED) IVD products, overseeing aspects such as reagent manufacturing, analytical QC, and scale-up processes. Previous positions include Senior Scientist at Pacific Biosciences, focusing on reagent development for NGS kits, and various leadership roles at Danaher Corporation and Molecular Devices, where significant contributions included launching multiple reagent products and developing patented technologies. James holds degrees from The University of Sheffield, Chinese Academy of Sciences, and University of California, Riverside.
This person is not in any teams
Nautilus Biotechnology
Nautilus (Nasdaq: NAUT) is a company with a vision to revolutionize biomedicine by unlocking the complexity of the human proteome. They are driven to transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across biomedical research and drug discovery.